PepGen SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 10, 2026, 8 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Other events · Financial statements and exhibits
AI summary, unreviewedPepGen Q3 2026 net loss $19.4 million, $(0.28) per share, vs $(0.27) consensus; positive 10 mg/kg FREEDOM2-DM1 data announced alongside results
8-KAug. 6, 2026, 7:40 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Other events · Financial statements and exhibits